2023 - Research.com Biology and Biochemistry in Australia Leader Award
The scientist’s investigation covers issues in Microvesicles, Virology, Cell biology, Bovine spongiform encephalopathy and Scrapie. His Microvesicles research focuses on Exosome in particular. His Virology study integrates concerns from other disciplines, such as Phenotype, Transmissible spongiform encephalopathy, In vivo and Antiretroviral therapy.
The study incorporates disciplines such as Secretion, Extracellular vesicle, Alpha-synuclein and Amyloid precursor protein in addition to Cell biology. He has included themes like Tonsil, Immunology, Creutzfeldt-Jakob Syndrome and Biopsy in his Bovine spongiform encephalopathy study. His research in Scrapie intersects with topics in Infectivity, Proteinase K and Hamster.
Andrew F. Hill mainly focuses on Cell biology, Virology, Microvesicles, Internal medicine and Biochemistry. His Cell biology study combines topics in areas such as Biogenesis, Alpha-synuclein and Amyloid precursor protein. Andrew F. Hill has researched Virology in several fields, including Scrapie, PrPSc Proteins, Transmissible spongiform encephalopathy, Bovine spongiform encephalopathy and Disease.
His Bovine spongiform encephalopathy study focuses on Transmissible mink encephalopathy in particular. His Microvesicles research incorporates themes from RNA and Extracellular vesicles. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Endocrinology, Oncology and Emtricitabine.
His primary scientific interests are in Cell biology, Microvesicles, Internal medicine, Extracellular vesicles and Disease. His Cell biology research is multidisciplinary, incorporating elements of Small RNA, Neurodegeneration and Amyloid precursor protein. His Microvesicles research is multidisciplinary, incorporating perspectives in Pathogenesis, Sphingolipid, Proteomics, Parkinson's disease and Mesenchymal stem cell.
His research in the fields of Prospective cohort study overlaps with other disciplines such as Ipilimumab. His work focuses on many connections between Extracellular vesicles and other disciplines, such as Computational biology, that overlap with his field of interest in Nanoparticle, Heterogeneous population, In vivo, In vitro and Cellular origin. His research integrates issues of Genotype, microRNA, Function and Brain tissue in his study of Disease.
His primary areas of investigation include Microvesicles, Extracellular vesicles, Internal medicine, Neuroscience and microRNA. His study in Microvesicles is interdisciplinary in nature, drawing from both Small RNA, Proteomics, Disease and Cell biology. He studies Cell biology, namely Endosome.
His study on Intention-to-treat analysis, Phases of clinical research and Odds ratio is often connected to Ipilimumab as part of broader study in Internal medicine. The various areas that Andrew F. Hill examines in his Neuroscience study include Lewy body, Neurotoxicity, Alpha-synuclein and Amyloid. He interconnects Biomarker, Transgene, Disease biomarker and Pathogenesis in the investigation of issues within microRNA.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Minimal information for studies of extracellular vesicles 2018 (MISEV2018) : a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
Clotilde Théry;Kenneth W. Witwer;Elena Aikawa;Maria Jose Alcaraz.
Journal of extracellular vesicles (2018)
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Jedd D. Wolchok;Vanna Chiarion-Sileni;Rene Gonzalez;Piotr Rutkowski.
The New England Journal of Medicine (2017)
Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD
John Collinge;John Collinge;Katie C. L. Sidle;Julie Meads;James Ironside.
Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles.
Jan Lötvall;Andrew F Hill;Fred H. Hochberg;Edit I Buzás.
Journal of extracellular vesicles (2014)
Five-year survival with combined nivolumab and ipilimumab in advanced melanoma: New England Journal of Medicine
J. Larkin;V. Chiarion-Sileni;R. Gonzalez;J.-J. Grob.
The New England Journal of Medicine (2019)
The same prion strain causes vCJD and BSE
Andrew F. Hill;Melanie Desbruslais;Susan Joiner;Katie C. L. Sidle.
Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation
Hina Kalra;Richard J. Simpson;Hong Ji;Elena Aikawa.
PLOS Biology (2012)
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial.
Frank Stephen Hodi;Vanna Chiarion-Sileni;Rene Gonzalez;Jean Jacques Grob.
Lancet Oncology (2018)
Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper
Thomas Lener;Mario Gimona;Ludwig Aigner;Verena Börger.
Journal of extracellular vesicles (2015)
Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples
AF Hill;RJ Butterworth;S Joiner;G Jackson.
The Lancet (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: